This study is in progress, not accepting new patients
Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
Summary
- Eligibility
- for people ages 18-130 (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Zev Wainberg (ucla)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Zev Wainberg (ucla)
HS Clinical Professor, Medicine. Authored (or co-authored) 159 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AstraZeneca
- ID
- NCT04999969
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 126 people participating
- Last Updated